Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated µ- and δ-opioid receptors
Authors:
- 1 March 1987
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 335 (3) , 278-284
Abstract
D-1 dopamine receptor-stimulated cyclic AMP efflux from rat neostriatal slices (induced by 30 μM dopamine + 10 μM (−)sulpiride) was concentration-dependently reduced by morphine, [abetd-Ala-abetd-Leu]-enkaphalin (DADLE), [d-Pen-abetd-Pen]enkephalin (DPDPE) and bremazocine. Naloxone (0.1 μM) selectively antagonized the inhibitory effect of (a submaximally effective concentration of) morphine, whereas ICI 174864 (0.75 μM) completely blocked the inhibitory effects of DADLE, DPDPE and bremazocine without affecting that of morphine, indicating a role of µ- as well as δ-opioid receptors. Upon simultaneous activation of D-1 dopamine receptors and b-opioid receptors the (μ-receptor-mediated) inhibitory effect of morphine was abolished, while it was not changed following simultaneous activation of D-1 and (inhibitory) D-2 dopamine receptors. Cyclic AMP efflux induced by isoprenaline or adenosine was not affected by the opioids and that induced by vasoactive intestinal peptide (VIP) was inhibited by morphine and DADLE only. In the latter case naloxone, but not ICI 174864, antagonized the inhibitory effects. These data show that D-1 dopamine receptor-stimulated adenylate cyclase activity in rat neostriatum, but not that stimulated through other receptors, is inhibited by two pharmacologically distinct opioid receptor subtypes. It is speculated that these μ- and δ-opioid receptors share a common inhibitory guanine nucleotide binding protein and may represent closely associated recognition sites of a functional opioid receptor complex.Keywords
This publication has 18 references indexed in Scilit:
- Pertussis toxin treatment modifies opiate action in the rat brain striatumBiochemical and Biophysical Research Communications, 1985
- Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography.Proceedings of the National Academy of Sciences, 1985
- Aα-Opiate Receptor in 7315c Tumor Tissue Mediates Inhibition of Immunoreactive Prolactin Release and Adenylate Cyclase ActivityEndocrinology, 1984
- Solubilization and characterization of mu, delta, and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors.Proceedings of the National Academy of Sciences, 1984
- Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.Proceedings of the National Academy of Sciences, 1983
- Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.Molecular Pharmacology, 1983
- Isolation of opiate binding components by affinity chromatography and reconstitution of binding activities.Proceedings of the National Academy of Sciences, 1983
- Both ν and δ Opiate Receptors Exist on the Same NeuronScience, 1981
- Interconverting mu and delta forms of the opiate receptor in rat striatal patches.Proceedings of the National Academy of Sciences, 1981
- Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatumNature, 1981